Unlocking New Liquid Biopsy Cancer Markers with Centrifugal Microfluidics, CIF 2025, Part 2

COMPAMED Innovation Forum 2025 – Online Lecture by Dr. J. Lüddecke This year's COMPAMED Innovation Forum was dedicated to the latest trends and technologies in cancer diagnostics. The online event was aimed at companies that develop components and systems for medical technology, as well as medical professionals who want to find out about the latest developments. In this expert talk from the COMPAMED Innovationsforum 2025 on “Pioneering Cancer Detection: From Early Diagnosis to Precision Medicine”,Dr. J. Lüddecke, Hahn-Schickard, presents “Unlocking New Liquid Biopsy Cancer Markers with Centrifugal Microfluidics”. Session Chair is Dr. Jens Ebnet, Ebnet Medical GmbH, Schwerin, DE This presentation explores the potential of centrifugal microfluidics to unlock novel cancer biomarkers through liquid biopsy, paving the way for earlier detection, minimally invasive diagnostics and more personalized treatment strategies. The webinar was organized by IVAM Microtechnology Network in cooperation with Messe Düsseldorf. The aim is to highlight current challenges, solutions and prospects for the industry - with a view to the upcoming COMPAMED, Europe's leading trade fair for medical suppliers.